Default company panoramic image

Synteny Inc.

Building clinical trial management system to open the market for Pet Clinical trials, curing dogs and giving unique insights to biopharma

  • Stage Product In Development
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded August 2012
  • Employees 2
  • Website

Company Summary

Connecting 150 millions pets and the drug development process. BioPharma needs insights into efficacy and dosages to avoid failure in the human clinical trial path. Our Pet clinical trial software enables quick spin up of trials in a cost effective and data compliant way. Pet owners and their pets benefit from access to cures not available, care from our network of vets at reduced costs.


  • Default avatar
    Veronica Maldonado
    Co-founder and CEO

    Extensive preclinical experience (over 15 years) in human drug development applying various rodent models in therapeutic areas for metabolic disorders, heart failure and cancer. Earned Doctorate in Veterinary Medicine (DVM) and PhD in Molecular Immunology and is Boarded in Laboratory Animal Medicine (ACLAM). Dedicated full time to opening a new market for clinical trials on sick pets for both their benefit and advancement of human therapeutics.

  • Default avatar
    Bruno Rocca
    Co-founder and COO

    UCB Engineer and growth architect with 20 years experience building healthcare systems and co-founder of three successful technology companies. Specialist in building clinical trials and managing the patient recruitment process and integrating technology into the process.

  • Default avatar
    Jonathan Betts-Lacroix

    scientist, inventor and entrepreneur in biophysics, geochemistry & electronics. Began as an electronics designer in HS, received his degree at Harvard in Environmental Geoscience, published quantum tunneling research (Science) from his fellowship at Caltech, built robots at MIT, founded OQO (world's smallest PC, Guinness 2006), filed & sold scores of patents in thermal engineering, user interfaces, electronics miniaturization and cloud computing.


  • Default avatar
    Default avatar
    Young Craig & Co